Coping With Epilepsy Neurofeedback Practitioner Directory
Sponsored Advertisement
 

Go Back   Epilepsy Forum > Peer Support > The Library



Reply
 
LinkBack Thread Tools Display Modes
  #1  
Old 09-15-2008, 02:29 PM
batman's Avatar
Been around the epilepsy block a few times
 
Join Date: Jun 2008
Posts: 29

Keppra XR Approved in the U.S.


Found out about this via the Keppra XR Approved for Partial-Onset Seizures
For people 16 and older
__________________
Bruce *I'm not a doctor, but the information I share is what I've learned and experienced due to having epilepsy myself. communityforum.epilepsysupportgroup.com

Last edited by brain; 09-16-2008 at 12:44 AM. Reason: added correct link and made link live
Add Post to del.icio.usNetscape this post!Stumble this Post!
Reply With Quote
  #2  
Old 09-16-2008, 12:46 AM
brain's Avatar
Super Moderator
 
Join Date: Feb 2007
Location: Tampa Bay Region, Florida
Posts: 2,972

Post


Just to add the quote:

Quote :
Keppra XR Approved for Partial-Onset Seizures
For people 16 and older

By Scott Roberts

MONDAY, Sept. 15 (HealthDay News) -- The U.S. Food and Drug Administration has approved an extended release form of Keppra (levetiracetam) as an add-on treatment for people with epileptic seizures aged 16 and older, Belgian drug maker UCB said Monday.

"While many people with epilepsy are successfully treated with one or more of the currently available anti-epileptic drugs, a significant percentage still live with uncontrolled seizures or intolerable side effects," the company said in a news release.

Once-daily Keppra XR is expected to be available at U.S. pharmacies by the end of the month, UCB said. The original form was approved in 1999.

In clinical testing, the most common side effects included drowsiness and irritability, which also are common side effects of the drug's immediate-release form.

More than 3 million people in the United States have epilepsy, and more than 40 percent of people who take only a single anti-epileptic drug continue to have seizures, the company said.
__________________
Sharon

Support the Team STIGMA TERMINATORS

HEADSTORMS RESOURCE CENTER

" Vujà Dé - The feeling you've never been in here before! "
Add Post to del.icio.usNetscape this post!Stumble this Post!
Reply With Quote
  #3  
Old 09-16-2008, 09:54 AM
Bernard's Avatar
Your Host
 
Join Date: Mar 2005
Location: Friendswood, TX
Posts: 4,156

FDA approves Keppra XR as add-on for 16 year olds


Here is the original press release:
Quote :
Keppra XR™ approved in the U.S.

BRUSSELS, BELGIUM--(Marketwire - September 15, 2008) -

* As adjunctive therapy, Keppra XR offers significant partial
onset seizure reduction, proven tolerability, and once-daily
dosing

* Keppra XR is built on a trusted heritage


Brussels, BELGIUM - September 15, 2008 at 7:00 am CEST - press release, regulated information: UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra XR™ (levetiracetam extended-release tablets) for use as an add-on to other antiepileptic treatments for people with partial onset seizures who are 16 years of age and older. Keppra XR™ is expected to be available in U.S. pharmacies at the end of September 2008.

The goal of therapy with antiepileptic drugs (anti-epileptic drugs) is freedom from seizures and minimal side effects. While many people with epilepsy are successfully treated with one or more of the currently available anti-epileptic drugs, a significant percentage still live with uncontrolled seizures or intolerable side effects.

"With solid clinical trial data supporting Keppra XR™ efficacy and tolerability, this once-daily antiepileptic drug can play an important role in treating people with epilepsy," said lead investigator Dr. Jukka Peltola, Department of Neurology, Tampere University Hospital, Finland. "We found in the clinical trial that Keppra XR™ provided significant partial onset seizure control in once-daily dosing when added to other antiepileptic drugs and that it was generally well-tolerated."

Building On A Trusted Heritage

"This is one of many milestones at UCB to develop new treatment options for people with epilepsy," said Troy Cox, Senior Vice President UCB & President CNS Operations. "Keppra XR™ provides a way to simplify treatment and offers another chance to achieve seizure control, which is an important goal for patients living with epilepsy."

The immediate release tablet form of Keppra® (levetiracetam) was first approved by the FDA in 1999 as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy. Since then, Keppra® has become a leading antiepileptic drug in the U.S.

Important Safety Information

Keppra XR™ extended release tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in patients 16 years of age and older with epilepsy. Keppra XR™ causes somnolence, dizziness, and behavioural abnormalities. The most common adverse reactions observed with Keppra XR™ combination with other anti-epileptic drugs were somnolence and irritability. The adverse reactions that may be seen in patients receiving Keppra XR™ are expected to be similar to those seen in patients receiving immediate-release Keppra® tablets.

Keppra® immediate-release tablets cause somnolence and fatigue, coordination difficulties, and behavioural abnormalities (e.g., psychotic symptoms, suicidal ideation, and other abnormalities) as well as hematological abnormalities. In adults experiencing partial onset seizures, the most common adverse reactions observed with Keppra® in combination with other anti-epileptic drugs were somnolence, asthenia, infection and dizziness.

Keppra XR™ should be gradually withdrawn to minimize the potential of increased seizure frequency.

Dosing must be individualized according to the patient's renal function state. The dosage should be reduced in patients with impaired renal function receiving Keppra XR™. In patients with end stage renal disease on dialysis, it is recommended that immediate-release Keppra® be used instead of Keppra XRTM.

For full prescribing information, please see www.KeppraXR.com.

In order to ensure patient access to this valuable medication in the U.S., UCB is initiating a co-pay support program. For more information, contact the U.S. UCB Medical Information at 1-866-822-0068 (press 9).
__________________


Check out this chart of alternative epilepsy treatments and this page on EEG Neurofeedback

Would you like to help support this forum?
Add Post to del.icio.usNetscape this post!Stumble this Post!
Reply With Quote
  #4  
Old 09-16-2008, 11:40 AM
batman's Avatar
Been around the epilepsy block a few times
 
Join Date: Jun 2008
Posts: 29
Let me try this again.

The first link I had posted was for the 'Epilepsy Wire: Comprehensive News Feed for Epilepsy', which is at...

www.topix.net/wire/health/epilepsy

and the second, was a direct link to the Keppra XR website, which is at...

www.keppraxr.com

At this moment, on the first page of the results for the 'Epilepsy Wire' site, I see that there are 5 separate listings that pertains to the Keppra XR. And each one of those listed are to separate news stories.
__________________
Bruce *I'm not a doctor, but the information I share is what I've learned and experienced due to having epilepsy myself. communityforum.epilepsysupportgroup.com
Add Post to del.icio.usNetscape this post!Stumble this Post!
Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Question about Keppra shomann The Foyer 1 05-08-2008 01:49 PM
Keppra/Lyrica Sandee The Foyer 2 04-07-2008 10:22 PM
keppra or not minnbikergirl The Foyer 11 04-05-2008 10:28 AM
Keppra maureen The Kitchen 6 12-02-2007 11:46 AM
Lyrica approved for Epilepsy by the FDA Bernard The Kitchen 0 07-09-2005 03:22 PM


All times are GMT -5. The time now is 06:41 PM.


Powered by vBulletin® - Copyright ©2000 - 2009, Jelsoft Enterprises Ltd.
Content Relevant URLs by vBSEO ©2008, Crawlability, Inc.
Copyright 2005 © Measuring Up. ALL rights reserved.